Edwards Hedges Bets Between Percutaneous And Surgical Heart Valves
This article was originally published in The Gray Sheet
Executive Summary
Edwards Lifesciences will continue developing new surgical heart valves, in addition to potentially more lucrative percutaneous valve technologies